Autoimmune diabetes is characterized by an inflammatory reaction in and around pancreatic islets, followed by selective destruction of ?-cells. The broad goals of this research are to elucidate the cellular mechanisms that are responsible for pancreatic ?-cells death and to identify mechanisms by which ?-cells protect themselves against cytokine- and free radical-mediated damage. Nitric oxide, the primary mediator of the inhibitory actions of interleukin-1 (IL-1) and interferon-? (IFN-?) on ?-cell function, also activates a """"""""recovery"""""""" pathway that protects ?-cells from cytokine-mediated damage. It is the delicate balance between the toxic and protective actions of nitric oxide that ultimately determine the susceptibility of ?-cells to cytokine- mediated damage. This proposal focuses on elucidating the cellular pathways by which cytokines stimulate ?-cell death, the pathways responsible for ?-cell recovery from cytokine- and free radical-mediated damage, and how these pathways interact to determine ?-cell fate. There are three specific aims. 1. To test the hypothesis that irreversible inhibition of ?-cell function is associated with a switch in the mechanism of cytokine-induced death from necrosis to apoptosis and that the rate of nitric oxide production, the cellular levels of NAD, and the extent of DNA damage contribute to this mechanistic switch. 2. To test the hypothesis that nitric oxide activates AMPK in ?-cells and that AMPK is essential for the """"""""functional recovery"""""""" of ?-cells from cytokine- and nitric oxide-mediated damage. 3. To test the hypothesis that FoxO1 is a primary regulator controlling the response of ?-cells to cytokines and nitric oxide. Under conditions in which ?-cells have the ability to recover from cytokine-mediated damage, FoxO1 directs a transcriptional program affording ?-cells protection from oxidative stress. When -cells are committed to cytokine-mediated death, FoxO1 regulates a transcriptional program that directs ?-cell apoptosis. A number of biochemical, molecular biological, immunological, cell biological, and transgenic techniques will be utilized to investigate the cellular pathways through which nitric oxide mediates ?-cell destruction and the pathways that participate in the protection of ?-cells from cytokine-mediated damage. It is hoped that insights into the mechanisms of cytokine-mediated damage and protection from this damage gained from these studies will influence the design of therapeutic strategies aimed at the prevention and treatment of this debilitating disorder.

Public Health Relevance

Autoimmune diabetes is characterized by an inflammatory reaction in and around pancreatic islets, followed by selective destruction of ?-cells. The broad goals of this research are to elucidate the cellular mechanisms that are responsible for pancreatic ?-cells death and to identify mechanisms by which ?-cells protect themselves against cytokine- and free radical- mediated damage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052194-16
Application #
8111055
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Appel, Michael C
Project Start
1998-01-01
Project End
2013-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
16
Fiscal Year
2011
Total Cost
$345,902
Indirect Cost
Name
Medical College of Wisconsin
Department
Biochemistry
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Kropp, Erin M; Broniowska, Katarzyna A; Waas, Matthew et al. (2017) Cardiomyocyte Differentiation Promotes Cell Survival During Nicotinamide Phosphoribosyltransferase Inhibition Through Increased Maintenance of Cellular Energy Stores. Stem Cells Transl Med 6:1191-1201
Schwab, Andrew J; Sison, Samantha L; Meade, Michael R et al. (2017) Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons. Stem Cell Reports 9:1839-1852
Samson, Willis K; Stein, Lauren M; Elrick, Mollisa et al. (2016) Hypoglycemia unawareness prevention: Targeting glucagon production. Physiol Behav 162:147-50
Elrick, Mollisa M; Samson, Willis K; Corbett, John A et al. (2016) Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic ?-cells. Am J Physiol Regul Integr Comp Physiol 310:R143-55
Oleson, Bryndon J; Broniowska, Katarzyna A; Naatz, Aaron et al. (2016) Nitric Oxide Suppresses ?-Cell Apoptosis by Inhibiting the DNA Damage Response. Mol Cell Biol 36:2067-77
Hye Khan, Md Abdul; Hwang, Sung Hee; Sharma, Amit et al. (2016) A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat 125:40-7
Shaheen, Zachary R; Corbett, John A (2015) Macrophage Expression of Inflammatory Genes in Response to EMCV Infection. Biomolecules 5:1938-54
Broniowska, Katarzyna A; Mathews, Clayton E; Corbett, John A (2015) Reply to Gurgul-Convey and Lenzen: Cytokines, nitric oxide, and ?-cells. J Biol Chem 290:10571
Shaheen, Zachary R; Naatz, Aaron; Corbett, John A (2015) CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection. J Immunol 195:4406-14
Yosten, Gina L C; Elrick, Mollisa M; Salvatori, Alison et al. (2015) Understanding peptide biology: The discovery and characterization of the novel hormone, neuronostatin. Peptides 72:192-5

Showing the most recent 10 out of 70 publications